Bet on These 5 Dividend Growth Stocks Amid Rising Treasury YieldsZacks Investment Research • 09/25/26
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to KnowZacks Investment Research • 09/25/26
Amgen price target raised by Jefferies to $410 after positive Sjögren's dataProactive Investors • 09/23/26
AMGN's Dazodalibep Meets Goal in Systemic Sjogren's Disease StudyZacks Investment Research • 09/23/26
Amgen Hits Primary Endpoint In Sjögren's Trial, But Approval Filing Awaits Another Trial DataBenzinga • 09/22/26
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR DAZODALIBEP IN MODERATE-TO-SEVERE SYSTEMIC SJÖGREN'S DISEASEPRNewsWire • 09/22/26
Worried About a Market Crash? This Dividend Stock Outperformed as the S&P 500 Sank in Both 2008 and 2022The Motley Fool • 09/16/26
September Syndrome in Full Swing: 3 Picks to Safeguard Your PortfolioZacks Investment Research • 09/16/26
Amgen Inc. (AMGN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/15/26
4 Defensive Stocks to Take Refuge in as Consumer Sentiment PlummetsZacks Investment Research • 09/15/26
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending StockZacks Investment Research • 09/14/26
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 09/14/26